Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer
Authors
Keywords
-
Journal
Nature Communications
Volume 4, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-07-19
DOI
10.1038/ncomms3175
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular Pathways: Current Role and Future Directions of the Retinoic Acid Pathway in Cancer Prevention and Treatment
- (2013) R. M. Connolly et al. CLINICAL CANCER RESEARCH
- BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib
- (2012) M F E Godinho et al. BRITISH JOURNAL OF CANCER
- Protein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell lines
- (2012) Ton van Agthoven et al. INTERNATIONAL JOURNAL OF CANCER
- Next-generation proteomics: towards an integrative view of proteome dynamics
- (2012) A. F. Maarten Altelaar et al. NATURE REVIEWS GENETICS
- The Proteomics Identifications (PRIDE) database and associated tools: status in 2013
- (2012) Juan Antonio Vizcaíno et al. NUCLEIC ACIDS RESEARCH
- All-trans retinoic acid induces cellular senescence by up-regulating levels of p16 and p21 via promoter hypomethylation
- (2011) Joo Song Lim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- All-trans retinoic acid induces cellular senescence via upregulation of p16, p21, and p27
- (2011) Sun-Hye Park et al. CANCER LETTERS
- Emerging data on the efficacy and safety of fulvestrant, a unique antiestrogen therapy for advanced breast cancer
- (2011) Sarah M Scott et al. Expert Opinion On Drug Safety
- Global quantification of mammalian gene expression control
- (2011) Björn Schwanhäusser et al. NATURE
- Epigenetic regulation by RARα maintains ligand-independent transcriptional activity
- (2011) Kristian B. Laursen et al. NUCLEIC ACIDS RESEARCH
- Vascular endothelial growth factor receptor 2 and downstream p38 mitogen-activated protein kinase are possible candidate markers of intrinsic resistance to adjuvant endocrine treatment in steroid receptor positive breast cancer
- (2010) Barbro K. Linderholm et al. BREAST CANCER RESEARCH AND TREATMENT
- Prolonged tamoxifen treatment increases relapse-free survival for patients with primary breast cancer expressing high levels of VEGF
- (2010) B.C. Sanchez et al. EUROPEAN JOURNAL OF CANCER
- Cooperative interaction between retinoic acid receptor- and estrogen receptor in breast cancer
- (2010) C. S. Ross-Innes et al. GENES & DEVELOPMENT
- Future of Personalized Medicine in Oncology: A Systems Biology Approach
- (2010) Ana Maria Gonzalez-Angulo et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic Index of Sensitivity to Endocrine Therapy for Breast Cancer
- (2010) W. Fraser Symmans et al. JOURNAL OF CLINICAL ONCOLOGY
- Mechanism of inhibition of MMTV-neu and MMTV-wnt1 induced mammary oncogenesis by RARα agonist AM580
- (2010) Y Lu et al. ONCOGENE
- Genomic Antagonism between Retinoic Acid and Estrogen Signaling in Breast Cancer
- (2009) Sujun Hua et al. CELL
- Differential Action on Coregulator Interaction Defines Inverse Retinoid Agonists and Neutral Antagonists
- (2009) Pierre Germain et al. CHEMISTRY & BIOLOGY
- Randomized Double-Blind 2 × 2 Trial of Low-Dose Tamoxifen and Fenretinide for Breast Cancer Prevention in High-Risk Premenopausal Women
- (2009) Andrea Decensi et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene-Expression Signatures in Breast Cancer
- (2009) Christos Sotiriou et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functional identification of genes causing estrogen independence of human breast cancer cells
- (2008) Ton van Agthoven et al. BREAST CANCER RESEARCH AND TREATMENT
- ERα negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor
- (2008) Jiang Fan et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Relevance of Breast Cancer Antiestrogen Resistance Genes in Human Breast Cancer Progression and Tamoxifen Resistance
- (2008) Ton van Agthoven et al. JOURNAL OF CLINICAL ONCOLOGY
- An Autocrine VEGF/VEGFR2 and p38 Signaling Loop Confers Resistance to 4-Hydroxytamoxifen in MCF-7 Breast Cancer Cells
- (2008) R. Aesoy et al. MOLECULAR CANCER RESEARCH
- Regulation of ERBB2 by oestrogen receptor–PAX2 determines response to tamoxifen
- (2008) Antoni Hurtado et al. NATURE
- Quantitative membrane proteomics applying narrow range peptide isoelectric focusing for studies of small cell lung cancer resistance mechanisms
- (2008) Hanna Eriksson et al. PROTEOMICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search